PDCD1 and malignant colon neoplasm: Besides, the study of a colon cancer MC38 mouse model has demonstrated that a higher fraction of both the PD-1+ TAMs and the PD-1+ tumor-infiltrating lymphocytes (TILs) derived from circulating leukocytes contributes to immunosuppression in the TME, and increases tumor burden [48].